A study by the University of Iowa and the VA’s Center for the Prevention and Treatment of Visual Loss reports that a CBD–THC ...

Increasing evidence has shown that cannabis can help our understanding of neuropsychiatric diseases and shows promise in their treatment as well, especially autism and dementia.

A study on the safety and efficacy of low-dose THC-CBD cannabinoid extract in the treatment of patients with Alzheimer's ...

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...

UnityPoint Health - Meriter is celebrating its new training center, created to educate and train medical professionals in ...

UnityPoint Health - Meriter is celebrating its new training center, created to educate and train medical professionals in newborn care.

Through a five-year, $10.7 million National Institutes of Health grant awarded to Boise State University and co-led with ...

Non-cannabidiol (CBD) cannabinoids are associated with improvements in sleep quality, according to results of a systematic review and meta-analysis published in Sleep Medicine Reviews.

Despite regulatory progress in many countries, skepticism and a lack of robust randomized trials continue to limit the use of medical cannabis in rheumatology.